Société Monte Rosa Therapeutics, Inc.
Actions
GLUE
US61225M1027
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
4,85 USD | -6,37% | -14,16% | -14,16% |
Métier
Nombre d'employés: 130
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Markus Warmuth
CEO | Chief Executive Officer | 53 | 01/01/20 |
Chief Operating Officer | - | 01/03/21 | |
Filip Janku
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/06/21 |
Sharon Townson
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/07/20 |
Owen Wallace
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/02/21 |
John Castle
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/05/20 |
Philip Nickson
LAW | General Counsel | 45 | 01/03/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Andrew Schiff
CHM | Chairman | 58 | 01/09/20 |
Christine Siu
BRD | Director/Board Member | 47 | 01/12/20 |
Chandra Paul Leo
BRD | Director/Board Member | 53 | 01/09/20 |
Ali Behbahani
BRD | Director/Board Member | 47 | 01/04/20 |
Anthony Manning
BRD | Director/Board Member | 62 | 25/07/23 |
Markus Warmuth
CEO | Chief Executive Officer | 53 | 01/01/20 |
Jan Skvarka
BRD | Director/Board Member | 57 | 23/03/23 |
Director/Board Member | 55 | 01/06/20 | |
Alexander Mayweg
BRD | Director/Board Member | 49 | 01/04/18 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 50 522 024 | 49 892 025 ( 98,75 %) | 10 005 ( 0,0198 %) | 98,75 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-14,16% | 245 M | |
+17,96% | 44,96 Md | |
+1,17% | 42,65 Md | |
+46,68% | 41,85 Md | |
-4,27% | 29,04 Md | |
+11,42% | 26,08 Md | |
-21,39% | 19,03 Md | |
+4,86% | 12,75 Md | |
+27,29% | 12,06 Md | |
-3,50% | 11,75 Md |
- Bourse
- Actions
- Action GLUE
- Société Monte Rosa Therapeutics, Inc.